VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1572653
Sex: F
Age:
State: AL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: slightly raised red area; swelling at the site of the injection; soreness in the arm; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concurrent medical conditions included Insulin dependent diabetic. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness: Insulin dependent diabetic

ID: 1572654
Sex: F
Age:
State: TX

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Dizziness; Fatigue; Swelling arm; This spontaneous case was reported by a consumer and describes the occurrence of in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Asthma and Diabetes. Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and VITAMIN D3 for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN D3

Current Illness: Asthma; Diabetes

ID: 1572655
Sex: M
Age: 74
State: FL

Vax Date: 01/12/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Arm itch; Red; Hot; swollen; A spontaneous report was received from a consumer who was also a 74-years-old male patient who received Moderna's COVID-19 vaccine and experienced events like arm started to itch, it was swollen, red and hot,around the arm on deltoid. Patient's medical history and concomitant medicines was not provided. On 12-JAN-2021,patient received Moderna's COVID-19 vaccine on his left arm intramuscularly at a drive thru vaccination site Around the 18-JAN-2021 or 19-JAN-2021, her arm started to itch. On the 20-JAN-2021 it was swollen and on 22-JAN-2021 there was no itching but it is red and hot, around arm on the deltoid. Treatment actions was not provided. Action taken with mRNA-1273 was not reported. The outcome of the events, arm started to itch was recovered/resolved, and it was swollen, red and hot,around the arm on deltoid was unknown.

Other Meds:

Current Illness:

ID: 1572656
Sex: F
Age: 51
State: TX

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: headache; fever up to 101.5 ? F; swollen at the injection site; felt tired; itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itchiness at the injection site), INJECTION SITE SWELLING (swollen at the injection site), FATIGUE (felt tired), HEADACHE (headache) and PYREXIA (fever up to 101.5 ? F) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concomitant products included DULOXETINE for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at the injection site). On 06-Jan-2021, the patient experienced INJECTION SITE SWELLING (swollen at the injection site) and FATIGUE (felt tired). On 16-Jan-2021, the patient experienced HEADACHE (headache) and PYREXIA (fever up to 101.5 ? F). On 07-Jan-2021, INJECTION SITE SWELLING (swollen at the injection site) and FATIGUE (felt tired) had resolved. On 19-Jan-2021, HEADACHE (headache) had resolved. On 21-Jan-2021, PYREXIA (fever up to 101.5 ? F) had resolved. At the time of the report, INJECTION SITE PRURITUS (itchiness at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. Concomitant medication included lipid modifying agents.

Other Meds: DULOXETINE

Current Illness:

ID: 1572657
Sex: F
Age: 28
State: MA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Felt fatigued; Nausea; Chills; Muscle ache; Really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt fatigued), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Muscle ache) and HEADACHE (Really bad headache) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. Concomitant products included GALCANEZUMAB GNLM (EMGALITY [GALCANEZUMAB GNLM]) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced FATIGUE (Felt fatigued), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Muscle ache) and HEADACHE (Really bad headache). On 20-Jan-2021, FATIGUE (Felt fatigued), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Muscle ache) and HEADACHE (Really bad headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: EMGALITY [GALCANEZUMAB GNLM]; ADDERALL

Current Illness:

ID: 1572658
Sex: F
Age: 31
State: NY

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Red at the injection site; swollen at the injection site like a bump; itchy; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1572659
Sex: F
Age: 65
State: TX

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Nauseous; Extremely fatigued; Chills/ Shaking; Temperature went up to 102.3 degrees F/ Felt like she was on fire; Felt super weak; Felt really bad for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely fatigued), CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak) and NAUSEA (Nauseous) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Pneumonia (Covid pneumonia in the history.) in March 2020. On 16-Jan-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak) and MALAISE (Felt really bad for 2 days). On 16-Jan-2021 at 1:00 PM, the patient experienced FATIGUE (Extremely fatigued). On 18-Jan-2021, the patient experienced NAUSEA (Nauseous). On 20-Jan-2021, FATIGUE (Extremely fatigued), CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak), NAUSEA (Nauseous) and MALAISE (Felt really bad for 2 days) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1572660
Sex: F
Age: 87
State: FL

Vax Date: 01/12/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: redness at injection site; itchiness at injection site; injection site was also hard; injection site was hot; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site), INJECTION SITE INDURATION (injection site was also hard) and INJECTION SITE WARMTH (injection site was hot) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site), INJECTION SITE INDURATION (injection site was also hard) and INJECTION SITE WARMTH (injection site was hot). At the time of the report, INJECTION SITE ERYTHEMA (redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site), INJECTION SITE INDURATION (injection site was also hard) and INJECTION SITE WARMTH (injection site was hot) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was given Keflex, Benadryl, Pepcid by the doctor . No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1572661
Sex: F
Age: 37
State: FL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: diarrhea; first 24-48 she was feeling horrible; loss of apettite; myalgia; fever; vomiting; headache; rash in the back; This spontaneous case was reported by a health care professional and describes the occurrence of DECREASED APPETITE (loss of apettite) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DECREASED APPETITE (loss of apettite). At the time of the report, DECREASED APPETITE (loss of apettite) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient took Tylenol and Benadryl as treatment.

Other Meds:

Current Illness:

ID: 1572662
Sex: F
Age: 39
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: area is getting bigger; Warm to touch; Injected area was itching; Hardish; tenderness; Redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish) and VACCINATION SITE PAIN (tenderness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1572663
Sex: U
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Elevated blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Elevated blood pressure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Elevated blood pressure). At the time of the report, BLOOD PRESSURE INCREASED (Elevated blood pressure) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572664
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: adverse events; possible allergic reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction). At the time of the report, VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572665
Sex: F
Age: 83
State: NC

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: from her neck to her arm is having intense pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (from her neck to her arm is having intense pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032l208) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included MAGNESIUM, VITAMIN E NOS (VITAMIN E + MAGNESIUM), OMEPRAZOLE, blood pressure medication and blood sugar medication for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (from her neck to her arm is having intense pain). At the time of the report, PAIN (from her neck to her arm is having intense pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient took Tylenol to relieve the pain. Reporter did not allow further contact

Other Meds: VITAMIN E + MAGNESIUM; OMEPRAZOLE; blood pressure medication; blood sugar medication

Current Illness:

ID: 1572666
Sex: M
Age: 63
State: GA

Vax Date: 01/08/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Slight cough; Nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Slight cough) and NASAL CONGESTION (Nasal congestion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. No medical history was provided by the reporter. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Slight cough) and NASAL CONGESTION (Nasal congestion). At the time of the report, COUGH (Slight cough) and NASAL CONGESTION (Nasal congestion) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572667
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572668
Sex: F
Age: 71
State: GA

Vax Date: 01/14/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: right palm pain felt like it had a hot poker in it, rating 8-9; reports pain down her right arm; itchy rash; started to have a rash, smooth, reasonably hard, very itchy, and grew; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (started to have a rash, smooth, reasonably hard, very itchy, and grew), SKIN BURNING SENSATION (right palm pain felt like it had a hot poker in it, rating 8-9), PAIN IN EXTREMITY (reports pain down her right arm) and VACCINATION SITE RASH (itchy rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (started to have a rash, smooth, reasonably hard, very itchy, and grew) and VACCINATION SITE RASH (itchy rash). On an unknown date, the patient experienced SKIN BURNING SENSATION (right palm pain felt like it had a hot poker in it, rating 8-9) and PAIN IN EXTREMITY (reports pain down her right arm). At the time of the report, VACCINATION SITE RASH (started to have a rash, smooth, reasonably hard, very itchy, and grew), PAIN IN EXTREMITY (reports pain down her right arm) and VACCINATION SITE RASH (itchy rash) outcome was unknown and SKIN BURNING SENSATION (right palm pain felt like it had a hot poker in it, rating 8-9) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572669
Sex: F
Age: 80
State: CT

Vax Date: 01/12/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Very strange rash. It was 3 inches*1.5 inches wide; Infection in right arm just where nurse gave the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Very strange rash. It was 3 inches*1.5 inches wide) and VACCINATION SITE INFECTION (Infection in right arm just where nurse gave the vaccine) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (Very strange rash. It was 3 inches*1.5 inches wide) and VACCINATION SITE INFECTION (Infection in right arm just where nurse gave the vaccine). At the time of the report, VACCINATION SITE RASH (Very strange rash. It was 3 inches*1.5 inches wide) and VACCINATION SITE INFECTION (Infection in right arm just where nurse gave the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ELIQUIS

Current Illness:

ID: 1572670
Sex: F
Age: 57
State: CT

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: arm is about 2inches diameter; itchy, itchy, itchy; redness and itchiness around the injection site; redness and itchiness around the injection site; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site), VACCINATION SITE REACTION (arm is about 2inches diameter), PAIN (soreness) and PRURITUS (itchy, itchy, itchy) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site) and PAIN (soreness). On 22-Jan-2021, the patient experienced VACCINATION SITE REACTION (arm is about 2inches diameter) and PRURITUS (itchy, itchy, itchy). The patient was treated with HYDROCORTISONE (topical) in January 2021 for Adverse event, at a dose of UNK dosage form. On 18-Jan-2021, PAIN (soreness) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (redness and itchiness around the injection site), VACCINATION SITE PRURITUS (redness and itchiness around the injection site), VACCINATION SITE REACTION (arm is about 2inches diameter) and PRURITUS (itchy, itchy, itchy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: outcome of events changed to resolved

Other Meds:

Current Illness:

ID: 1572671
Sex: M
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have) and vaccination site pain (bruise-type feeling) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037K20A) for COVID-19 immunization. No medical history reported. On Jan 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 20, 2021, patient experienced nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have). On Jan 21, 2021, patient experienced vaccination site pain (bruise-type feeling). On Jan 22, 2021, vaccination site pain (bruise-type feeling): resolved. At the time of the report, nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information were provided. Reporter did not allow further contact.

Other Meds:

Current Illness:

ID: 1572672
Sex: M
Age: 66
State: FL

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Dizzy; vertigo; Feeling week; Tested positive for Covid-19; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19) and HEADACHE (Headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizzy), VERTIGO (vertigo), ASTHENIA (Feeling week), COVID-19 (Tested positive for Covid-19), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572673
Sex: F
Age: 64
State: PA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Slight soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slight soreness in arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (Slight soreness in arm). At the time of the report, VACCINATION SITE PAIN (Slight soreness in arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds: MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1572674
Sex: F
Age: 43
State: CA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Arm hurt; Injection site was swollen; Injection site was itching; Injection site was red, spread out a bit; Low-grade fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit) and PYREXIA (Low-grade fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (LOESTRIN) for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No treatment information provided.

Other Meds: LOESTRIN

Current Illness:

ID: 1572675
Sex: F
Age: 34
State: PA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Panic attack; Heart racing; Hands cold; Sweating; This spontaneous case was reported by a patient and describes the occurrence of PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ALBUTEROL SULFATE and HYDROXYZINE for an unknown indication. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating). At the time of the report, PANIC ATTACK (Panic attack), PALPITATIONS (Heart racing), PERIPHERAL COLDNESS (Hands cold) and HYPERHIDROSIS (Sweating) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Blood test: normal (normal) normal. On 05-Feb-2021, Electrocardiogram: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ALBUTEROL SULFATE; HYDROXYZINE

Current Illness:

ID: 1572676
Sex: F
Age: 50
State: GA

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Arm is red, swelling and itching; Arm is red, swelling and itching; Arm is red, swelling and itching; This spontaneous case was reported by a consumer and describes the occurrence of in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included MULTIVITAMINS [VITAMINS NOS] and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication. On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds: MULTIVITAMINS [VITAMINS NOS]; ZYRTEC ALLERGY

Current Illness:

ID: 1572677
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of vaccination site erythema (red circle at the injection site) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026L20A) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. On an unknown date, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced vaccination site erythema (red circle at the injection site). At the time of the report, vaccination site erythema (red circle at the injection site) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications and treatment information provided.

Other Meds:

Current Illness:

ID: 1572678
Sex: F
Age: 90
State: AL

Vax Date: 01/25/2021
Onset Date: 02/03/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: sore arm; itchy spot; red rash about 1 inch above the vaccine site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy spot), VACCINATION SITE RASH (red rash about 1 inch above the vaccine site) and VACCINATION SITE PAIN (sore arm) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy spot) and VACCINATION SITE RASH (red rash about 1 inch above the vaccine site). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PRURITUS (itchy spot), VACCINATION SITE RASH (red rash about 1 inch above the vaccine site) and VACCINATION SITE PAIN (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572679
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of rash (developed, 2 different types of rashes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced rash (developed, 2 different types of rashes). At the time of the report, rash (developed, 2 different types of rashes) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information provided.

Other Meds:

Current Illness:

ID: 1572680
Sex: U
Age:
State: KY

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Delayed Reactions 7-14 days after vaccination; Delayed Onset Pain on the Injection Site; Delayed Onset Redness a little lower than the Injection Site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (Delayed Reactions 7-14 days after vaccination), VACCINATION SITE PAIN (Delayed Onset Pain on the Injection Site) and VACCINATION SITE ERYTHEMA (Delayed Onset Redness a little lower than the Injection Site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed Reactions 7-14 days after vaccination), VACCINATION SITE PAIN (Delayed Onset Pain on the Injection Site) and VACCINATION SITE ERYTHEMA (Delayed Onset Redness a little lower than the Injection Site). At the time of the report, VACCINATION COMPLICATION (Delayed Reactions 7-14 days after vaccination), VACCINATION SITE PAIN (Delayed Onset Pain on the Injection Site) and VACCINATION SITE ERYTHEMA (Delayed Onset Redness a little lower than the Injection Site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572681
Sex: F
Age: 66
State: FL

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Stye in her eye; Case reference number MOD-2021-012942 is a report which refers to a 66 Years old Female patient. The patient experienced Stye in her eye. This occurred while participating in Protocol mRNA-1273 Moderna COVID-19 vaccine . The patients started Moderna COVID-19 Vaccine on . Some later, the patient developed Stye.' Relevant laboratory results were not reported and relevant physical signs were . The patient experienced the following serious criteria: The eventual diagnosis made was Hordeolum . The patient was treated for the event with antibiotic.The action taken for Moderna COVID-19 Vaccine was Unknown on . The event(s) were: Stye in her eye - Unknown. The investigator considered the Stye in her eye not related to the drug/placebo.

Other Meds:

Current Illness:

ID: 1572682
Sex: M
Age: 69
State: MO

Vax Date: 01/18/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Gone down sick; Dizzy; Feels weak; Fever; Headache; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever) and HEADACHE (Headache) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle ache). At the time of the report, VACCINATION COMPLICATION (Gone down sick), DIZZINESS (Dizzy), ASTHENIA (Feels weak), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Ibuprofen. Concomitant medicines taken by the patient included arthritis pills and cholesterol pills.

Other Meds:

Current Illness:

ID: 1572683
Sex: M
Age: 49
State: MA

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Dizziness; Lightheadedness; Rash; Headaches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), DIZZINESS (Lightheadedness), RASH (Rash) and HEADACHE (Headaches) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DIZZINESS (Lightheadedness), RASH (Rash) and HEADACHE (Headaches). At the time of the report, DIZZINESS (Dizziness), DIZZINESS (Lightheadedness) and HEADACHE (Headaches) had not resolved and RASH (Rash) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medications received by the patient include Ondansetron and meclizine.

Other Meds:

Current Illness:

ID: 1572684
Sex: F
Age: 34
State: NJ

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: are currently pregnant; sore arm; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (are currently pregnant) and VACCINATION SITE PAIN (sore arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by reporter. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Jun-2021. On 10-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (are currently pregnant) and VACCINATION SITE PAIN (sore arm). At the time of the report, EXPOSURE DURING PREGNANCY (are currently pregnant) had resolved and VACCINATION SITE PAIN (sore arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment information was provided. Estimated due date was 12 Jun 2021.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1572685
Sex: M
Age: 42
State: OR

Vax Date: 01/25/2021
Onset Date: 02/01/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: itchiness at the injection site; swelling at the injection site; tightness of the skin at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057G20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572686
Sex: F
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced HEADACHE (Headaches). At the time of the report, HEADACHE (Headaches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572687
Sex: F
Age: 31
State: IL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: fever 102F; chills; headache; very nauseous, like I was going to pass out; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (very nauseous, like I was going to pass out), PYREXIA (fever 102F), CHILLS (chills) and HEADACHE (headache) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in July 2020. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NAUSEA (very nauseous, like I was going to pass out). On 21-Jan-2021, the patient experienced PYREXIA (fever 102F), CHILLS (chills) and HEADACHE (headache). On 22-Jan-2021, NAUSEA (very nauseous, like I was going to pass out), PYREXIA (fever 102F), CHILLS (chills) and HEADACHE (headache) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572688
Sex: M
Age: 64
State: OR

Vax Date: 01/15/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Rash; Itch; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Rash) and VACCINATION SITE PRURITUS (Itch) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itch). On 22-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash). At the time of the report, VACCINATION SITE RASH (Rash) and VACCINATION SITE PRURITUS (Itch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572689
Sex: F
Age: 47
State: KY

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Numbness on neck, face and arm on side on injection; This spontaneous case was reported by a consumer and describes the occurrence of in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572690
Sex: F
Age: 65
State: OH

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (the arm hurts a little), anosmia (lost the sense of smell), nasal congestion (extremely congested) and fatigue (feels really exhausted) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch no. 039K202A) for COVID-19 immunization. Concurrent medical conditions included asthma. On Jan 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced vaccination site pain (the arm hurts a little) and fatigue (feels really exhausted). On Jan 22, 2021, patient experienced anosmia (lost the sense of smell) and nasal congestion (extremely congested). At the time of the report, vaccination site pain (the arm hurts a little), anosmia (lost the sense of smell), nasal congestion (extremely congested) and fatigue (feels really exhausted) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Products known to have been used by the patient, within two weeks prior to the event, included asthma inhaler. Treatment information not provided.

Other Meds:

Current Illness: Asthma

ID: 1572691
Sex: F
Age:
State: LA

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: tested positive for Covid-19; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for Covid-19) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572692
Sex: F
Age: 79
State: CO

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: 5 Bowel movement; This spontaneous case was reported by a consumer and describes the occurrence of FREQUENT BOWEL MOVEMENTS (5 Bowel movement) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 25J202A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FREQUENT BOWEL MOVEMENTS (5 Bowel movement). At the time of the report, FREQUENT BOWEL MOVEMENTS (5 Bowel movement) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572693
Sex: U
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of vaccination site warmth (warm to the touch at the injection site with itching), vaccination site rash (rash in the injection site) and vaccination site pruritus (warm to the touch at the injection site with itching) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 12, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced vaccination site warmth (warm to the touch at the injection site with itching), vaccination site rash (rash in the injection site) and vaccination site pruritus (warm to the touch at the injection site with itching). At the time of the report, vaccination site warmth (warm to the touch at the injection site with itching), vaccination site rash (rash in the injection site) and vaccination site pruritus (warm to the touch at the injection site with itching) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information provided. This case linked to MOD-2021-048030 (patient link).

Other Meds:

Current Illness:

ID: 1572694
Sex: F
Age: 75
State: MO

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: spitting up clear, thick mucous like liquid; tingling; her heart was racing too; a sore arm; chills; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The patient's past medical history included Clotting disorder (Rare blood clotting disorder. diagnosed 20 years back.) and Vertigo (diagnosed 20 years back). Concurrent medical conditions included Allergy (Allergic to latex and oxycontin). Concomitant products included LORATADINE and WARFARIN for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills). At the time of the report, REGURGITATION (spitting up clear, thick mucous like liquid), PARAESTHESIA (tingling), PALPITATIONS (her heart was racing too), VACCINATION SITE PAIN (a sore arm) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LORATADINE; WARFARIN

Current Illness: Allergy (Allergic to latex and oxycontin)

ID: 1572695
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: red mark about iron sized on her injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red mark about iron sized on her injection arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red mark about iron sized on her injection arm). At the time of the report, VACCINATION SITE ERYTHEMA (red mark about iron sized on her injection arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572696
Sex: F
Age: 49
State: NY

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Uncontrollable chills, tremors; Myalgias; Fatigue; Low-grade fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 in April 2020. On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2020, the patient experienced CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever). At the time of the report, CHILLS (Uncontrollable chills, tremors), MYALGIA (Myalgias), FATIGUE (Fatigue) and PYREXIA (Low-grade fever) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. Treatment medication was not reported. The patient reported that it was severe, much more severe than when she had COVID19. It lasted for 30 hours.

Other Meds:

Current Illness:

ID: 1572697
Sex: F
Age: 43
State: OK

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: scratchy throat/felt like it was burning; eustachian tubes felt like they were clogged; puffy tongue; rash on her throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 21-Jan-2021 for Adverse event, at a dose of UNK dosage form and PREDNISONE for Adverse event, at a dose of 50 mg once a day. On 21-Jan-2021, THROAT IRRITATION (scratchy throat/felt like it was burning), EUSTACHIAN TUBE DYSFUNCTION (eustachian tubes felt like they were clogged), RASH (rash on her throat) and SWOLLEN TONGUE (puffy tongue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. 13 minutes and 47 seconds after the injection while the patient was still in the waiting area, she had a scratchy throat and felt like it was on fire. The patient was brought to the emergency room and was given another Benadryl shot. The reaction abated after 2 hours. She was prescribed with Prednisone 50 mg once a day for five days as home medication. At the time of the call, patient claimed that she was fine.

Other Meds:

Current Illness:

ID: 1572698
Sex: F
Age: 66
State: FL

Vax Date: 01/12/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: hot to the touch, like this arm has fever at the injection site; itching at the injectin site; redness area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy, Allergy to animals (cats and dogs), Grass allergy and Seafood allergy. Concomitant products included ZINC, ASCORBIC ACID, BIOFLAVONOIDS NOS (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]) and VITAMIN D NOS for Vitamin supplementation, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE WARMTH (hot to the touch, like this arm has fever at the injection site), VACCINATION SITE PRURITUS (itching at the injectin site) and VACCINATION SITE ERYTHEMA (redness area at the injection site) outcome was unknown. The patient did not take any concomitant medication on the day of vaccination and started taking them again the day before the reaction occurred. The patient suspected that it could be interaction between vaccine and iodine in the Synthroid and hence suspended it. This case was linked to MOD-2021-150632 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Reporter address, Allergy, dosage regimen, action taken updated

Other Meds: ZINC; VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS]; VITAMIN D NOS; SYNTHROID

Current Illness: Allergy to animals (cats and dogs); Grass allergy; Penicillin allergy; Seafood allergy

ID: 1572699
Sex: F
Age: 55
State: TX

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Body aches; fingers were hurting from cold; fingers were hurting from cold; can't call them chills, but her body temperature got really low; feels too weak; broke into a fever and got to 101.4 F; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold), PYREXIA (broke into a fever and got to 101.4 F) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low). On 22-Jan-2021 at 9:15 AM, the patient experienced MYALGIA (Body aches). On 22-Jan-2021, MYALGIA (Body aches), PERIPHERAL COLDNESS (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) had resolved, PAIN IN EXTREMITY (fingers were hurting from cold) outcome was unknown. At the time of the report, FATIGUE (feels too weak) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101.4 (High) 101.4 degree Fahrenheit. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported. 15 minutes later to the vaccination, at 7.32, the patient left the clinic and was still good, until 9.15 the day of report, when she got body aches. At 9.40 she experienced "can't call them chills, but her body temperature got really low", her fingers were hurting from cold. At 10.30 she broke into a fever and got to 101.4?F.

Other Meds:

Current Illness:

ID: 1572700
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). On 21-Jan-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1572701
Sex: F
Age: 89
State: NC

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: crying that her heel was hurting so bad; toes were less-colored, white, pale (different from other foot); This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Pains in legs. Concomitant products included OXYCODONE HYDROCHLORIDE (OXYCONTIN) for an unknown indication. On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)). The patient was treated with MAGNESIUM SULFATE (EPSOM SALTS [MAGNESIUM SULFATE]) (topical) on 22-Jan-2021 for Adverse event, at a dose of UNK dosage form (took epsom salt bath). At the time of the report, CONDITION AGGRAVATED (crying that her heel was hurting so bad) and SKIN DISCOLOURATION (toes were less-colored, white, pale (different from other foot)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: OXYCONTIN

Current Illness: Pains in legs

ID: 1572702
Sex: M
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: face iitchy; Rash in his face and whole body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in his face and whole body) and PRURITUS (face iitchy ) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The patient had no known allergies before. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (Rash in his face and whole body) and PRURITUS (face iitchy ). At the time of the report, RASH (Rash in his face and whole body) and PRURITUS (face iitchy ) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm